CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$5.50
52W Range
$4.27 - $896.00
50D Avg
$7.74
200D Avg
$45.80
Market Cap
$6.51M
Avg Vol (3M)
$1.20M
Beta
0.50
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.